Pregnancy of Bili in details
Bili has been assigned to pregnancy category B by the FDA. Animal studies using doses up to 146 times the normal human dose failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy; however, data available suggest Bili use in human pregnancy is not associated with fetal toxicity or teratogenicity. Bili is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
See references
Bili breastfeeding
There are no data on the excretion of Bili into human milk. However, because of its low molecular, Bili may likely be excreted into milk. The manufacturer recommends that caution be used when administering Bili to nursing women.
See references
References for pregnancy information
- "Product Information. Kytril (Bili)." SmithKline Beecham, Philadelphia, PA.
References for breastfeeding information
- "Product Information. Kytril (Bili)." SmithKline Beecham, Philadelphia, PA.
References
- DailyMed. "GRANISETRON: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubMed Health. "Sancuso: This section provide the link out information of drugs collectetd in PubMed Health. ". http://www.ncbi.nlm.nih.gov/pubmedhe... (accessed September 17, 2018).
- FDA Pharm Classes. "FDA Pharmacological Classification: FDA published a final rule that amended the requirements for the content and format of approved labeling (prescribing information) for human prescription drug and biological products in January 2006.". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
Reviews
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
